Background Thrombocytopenia has been shown to occur soon after surgical biological
aortic valve replacement (AVR), and recently reported also after transcatheter valve …

Thrombocytopenia and impaired platelet function are known as intrinsic drawbacks of
cardiac surgery and extracorporeal life supports (ECLS). A number of different factors …

Background: The frequency and predictors of thrombocytopenia after transcatheter aortic
valve implantation (TAVI) are unclear. Methods and Results: This study enrolled 342 …

The publication of the 2020 ACC/AHA guidelines for the management of patients with heart
valve disease, while updating essential steps for clinical evaluation and diagnosis, and …

Objective Thrombocytopenia is common after transcatheter aortic valve implantation (TAVI)
and is associated with mortality and major complications, although the underlying …

We describe a rare case of autoimmune heparin-induced thrombocytopenia after
transcatheter aortic valve implantation in which antibodies against platelet factor 4/heparin …

Background There is little data on the impact of chronic thrombocytopenia (CTP) on
outcomes after transcatheter aortic valve repair (TAVR). Most studies are from single centers …

Background: Subclinical leaflet thrombosis occasionally occurs after transcatheter aortic
valve implantation (TAVI), but its exact etiology and relationship with thrombogenicity remain …

Thrombocytopenia has long been recognized as a likely event following aortic valve
replacement (AVR), either with mechanical or biological prosthesis, and its consequences …

Objective: Thrombocytopenia is common after transcatheter aortic valve implantation (TAVI)
and is associated with mortality and major complications, although the underlying …